EP BIOCOMPOSITES LIMITED (EPBIO.BO)
INR 159.85
(0.0%)
INR 159.85
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -12.43 Million | -7.94 Million | -42.8 Million | 345 Thousand | 6.97 Million |
| Net Income | 11.49 Million | 5.76 Million | 8.09 Million | 3.58 Million | 1.89 Million |
| Depreciation & Amortization | 1 Million | 996 Thousand | 662 Thousand | 3000.00 | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -42.23 Million | -4.89 Million | -70.52 Million | -6.01 Million | -23.45 Million |
| Other non-cash items | 17.29 Million | -9.8 Million | 18.96 Million | 2.77 Million | 28.53 Million |
| Investing Cash Flow | -1.63 Million | 224 Thousand | -4.68 Million | 2000.00 | - |
| Investments in PPE | -2.36 Million | -224 Thousand | -4.74 Million | -27 Thousand | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 728 Thousand | 448 Thousand | 55 Thousand | 29 Thousand | - |
| Financing Cash Flow | 4.85 Million | 28.07 Million | 47.57 Million | -25 Thousand | -30 Thousand |
| Debt repayment | -5.2 Million | -28.29 Million | -41.11 Million | -25 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -349 Thousand | 56.37 Million | 6.46 Million | - | -30 Thousand |
| Accounts receivables | -31.36 Million | 12.35 Million | -64.49 Million | -3.45 Million | -18.11 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -187 Thousand | 1.66 Million | -7.32 Million | -3.38 Million | -6.67 Million |
| Other working capital | -10.68 Million | -18.91 Million | 1.29 Million | 828 Thousand | 1.33 Million |
| Cash at beginning of period | 21.91 Million | 1.56 Million | 1.47 Million | 1.15 Million | - |
| Cash at end of period | 12.7 Million | 21.92 Million | 1.56 Million | 1.47 Million | 6.94 Million |
| Capital Expenditure | -2.36 Million | -224 Thousand | -4.74 Million | -27 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -9.21 Million | 20.35 Million | 83 Thousand | 322 Thousand | 6.94 Million |
| Free Cash Flow | -14.79 Million | -8.16 Million | -47.54 Million | 318 Thousand | 6.97 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.64 Million | 11.49 Million | 4.64 Million | 1.1 Million | 1.1 Million | 5.76 Million |
| Depreciation & Amortization | 274 Thousand | 1 Million | 274 Thousand | 230 Thousand | 230 Thousand | 996 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -20.2 Million | -42.23 Million | -20.2 Million | -909 Thousand | -909 Thousand | -4.89 Million |
| Other non-cash items | 10.28 Million | 17.29 Million | 10.28 Million | -1.63 Million | -1.63 Million | -9.8 Million |
| Investing Cash Flow | -892.5 Thousand | -1.63 Million | -893 Thousand | 76.5 Thousand | 76.5 Thousand | 224 Thousand |
| Investments in PPE | -1.05 Million | -2.36 Million | -1.05 Million | -121 Thousand | -121 Thousand | -224 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 166.5 Thousand | 728 Thousand | 166.5 Thousand | 197.5 Thousand | 197.5 Thousand | 448 Thousand |
| Financing Cash Flow | 3.07 Million | 4.85 Million | 3.07 Million | -647.5 Thousand | -647.5 Thousand | 28.07 Million |
| Debt repayment | - | -5.2 Million | - | - | - | -28.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3.07 Million | -349 Thousand | 3.07 Million | -647.5 Thousand | -647.5 Thousand | 56.37 Million |
| Accounts receivables | -14.97 Million | -31.36 Million | -14.97 Million | -705 Thousand | -705 Thousand | 12.35 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -1.01 Million | -187 Thousand | -1.01 Million | 925 Thousand | 925 Thousand | 1.66 Million |
| Other working capital | -4.21 Million | -10.68 Million | -4.21 Million | -1.12 Million | -1.12 Million | -18.91 Million |
| Cash at beginning of period | 500.00 | 21.92 Million | - | - | - | 1.56 Million |
| Cash at end of period | -2.82 Million | 12.7 Million | -2.82 Million | -1.77 Million | -1.77 Million | 21.92 Million |
| Capital Expenditure | -1.05 Million | -2.36 Million | -1.05 Million | -121 Thousand | -121 Thousand | -224 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.82 Million | -9.21 Million | -2.82 Million | -1.77 Million | -1.77 Million | 20.35 Million |
| Free Cash Flow | -6.07 Million | -14.79 Million | -6.06 Million | -1.32 Million | -1.32 Million | -8.16 Million |
API
688113
Q5T
DAVA
322000
ASAP